The findings and conclusions in this article are those of the authors and do not represent the official position of the Centers for Disease Control and Prevention.
Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States
Article first published online: 21 JUL 2009
Published 2009. This article is a US Government work and is in the public domain in the USA.
Journal of Diabetes
Volume 1, Issue 4, pages 296–303, December 2009
How to Cite
FORD, E. S., ZHAO, G., LI, C. and PEARSON, W. S. (2009), Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States. Journal of Diabetes, 1: 296–303. doi: 10.1111/j.1753-0407.2009.00046.x
- Issue published online: 27 OCT 2009
- Article first published online: 21 JUL 2009
- Received 27 May 2009; revised 10 July 2009; accepted 16 July 2009.
- metabolic syndrome;
- parathyroid hormone;
- vitamin D
Background: Some reports suggest that concentrations of vitamin D are inversely, whereas concentrations of parathyroid hormone (PTH) are directly, associated with prevalent metabolic syndrome. Because of lingering uncertainty about these associations, we examined the cross-sectional associations between serum concentrations of 25-hydroxyvitamin D3 and PTH with metabolic syndrome in a representative sample of adults in the US.
Methods: We used data from 1705 participants in the 2005–2006 National Health and Nutrition Examination Survey. Vitamin D was measured by radioimmunoassay, whereas PTH was measured using an electrochemiluminescent process.
Results: The mean concentration of vitamin D for participants with and without metabolic syndrome was 20.3 and 22.9 ng/mL, respectively (P = 0.001). The mean concentration of PTH for participants with and without metabolic syndrome was 44.5 and 41.0 pg/mL, respectively (P = 0.002). The age-adjusted mean concentrations of vitamin D (P for linear trend <0.001) decreased linearly, whereas PTH (P for linear trend = 0.002) increased linearly, as the number of components of metabolic syndrome increased. After adjusting for age, gender, physical activity, urinary albumin creatinine ratio, and concentrations of C-reactive protein and calcium, concentrations in the highest quintile of vitamin D [prevalence ratio (PR) = 0.59; 95% confidence interval (CI) 0.44–0.79], but not PTH (PR = 1.18; 95% CI 0.97–1.43), was significantly associated with prevalent metabolic syndrome.
Conclusion: Concentrations of vitamin D, but not PTH, were significantly associated with prevalent metabolic syndrome among US adults.